Precigen, Inc.
PGEN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001356090
In the last 90 days, Precigen, Inc. insiders filed 1 open-market purchase and 9 sales; 210 institutions reported holding it in 13F filings for Q2 2026, worth $799.6M in total; no superinvestor holds it.
Key figures
- Insider buysLast 90 days, $24.7K in total
- 1
- Insider sellsLast 90 days, $6.80M in total
- 9
- 13F holdersQ2 2026, +8 vs. previous quarter
- 210
- 13F valueReported value at the end of Q2 2026
- $799.6M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding PGEN, Q2 2026
No superinvestor reported holding PGEN at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Precigen, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 28, 2026 (view filing)8:39 PM ET | Aug 26 | 2 days | Kindler Jeffrey BDirector | SSale | −185.0K | $7.44 | −$1.38M | −91.5%17.1K after | |
| Aug 25, 2026 (view filing)5:30 PM ET | Aug 21 | 4 days | Agee Nancy HDirector | PPurchase | +3.41K | $7.23 | +$24.7K | +1.1%309.2K after | |
| Aug 25, 2026 (view filing)5:27 PM ET | Aug 21-25 | 4 days | Shah Rutul RChief Operating Officer | SSale | −50.0K | $7.50 | −$375.0K | −9.6%468.9K after | 2 lots10b5-1 |
| Aug 25, 2026 (view filing)5:25 PM ET | Aug 25 | Same day | Tennant PhilChief Commercial Officer | SSale | −79.2K | $7.50 | −$593.7K | −35.8%142.0K after | 10b5-1 |
| Aug 7, 2026 (view filing)5:04 PM ET | Aug 6 | 1 day | Shah Rutul RChief Operating Officer | SSale | −32.7K | $6.86 | −$224.6K | −6.6%465.0K after | 10b5-1 |
| Aug 3, 2026 (view filing)6:12 PM ET | Aug 3 | Same day | Shah Rutul RChief Operating Officer | SSale | −33.8K | $6.50 | −$219.5K | −6.4%497.8K after | 10b5-1 |
| Jul 31, 2026 (view filing)4:26 PM ET | Jul 31 | Same day | Thomasian Harry Jr.Chief Financial Officer | SSale | −100.0K | $6.06 | −$606.0K | −28.2%254.5K after | 10b5-1 |
| Jul 1, 2026 (view filing)6:22 PM ET | Jun 29-Jul 1 | 2 days | Thomasian Harry Jr.Chief Financial Officer | SSale | −200.0K | $5.57 | −$1.11M | −36.1%354.5K after | 2 lots10b5-1 |
| Jul 1, 2026 (view filing)6:21 PM ET | Jun 29 | 2 days | Shah Rutul RChief Operating Officer | SSale | −42.9K | $5.85 | −$251.1K | −7.9%497.8K after | 10b5-1 |
| Jul 1, 2026 (view filing)6:19 PM ET | Jun 29 | 2 days | Sabzevari HelenPresident and CEO | SSale | −346.8K | $5.89 | −$2.04M | −8.4%3.77M after | 10b5-1 |
Top 10 13F holders, Q2 2026
The largest institutional positions in Precigen, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Patient Capital Management, LLC | 19,036,976 | $108.5M | 3.61% | +1,219,589+6.8% | Added |
| BlackRock, Inc. | 17,146,921 | $97.7M | 0.00% | +1,923,730+12.6% | Added |
| State Street Corp | 12,002,465 | $68.4M | 0.00% | +1,112,341+10.2% | Added |
| Diametric Capital, LP | 9,269,926 | $52.8M | 5.62% | +2,468,138+36.3% | Added |
| Vanguard Capital Management LLC | 7,906,160 | $45.1M | 0.00% | +757,164+10.6% | Added |
| Tang Capital Management LLC | 6,417,500 | $36.6M | 1.66% | 00.0% | Unchanged |
| Boxer Capital Management, LLC | 5,150,000 | $29.4M | 2.21% | +1,650,000+47.1% | Added |
| Geode Capital Management, LLC | 5,019,028 | $28.6M | 0.00% | +405,599+8.8% | Added |
| Iridian Asset Management LLC | 4,031,963 | $23.0M | 7.90% | +439,233+12.2% | Added |
| Morgan Stanley | 3,469,628 | $19.8M | 0.00% | +1,055,306+43.7% | Added |